Sort
48,018 grants matching “immunotherapy”
Phase I Trial of a HER2 ICD Plasmid-Based DNA Vaccine
$367,441University Of Washington · R01 · FY2003 · CA
Project 1: Priming and propagating immunity against head and neck cancer using targeted radionuclide therapy
$367,423Zachary Scott Morris · University Of Wisconsin-Madison · P50 · FY2022 · CA
Mechanisms of cell regulation and transformation
$367,398Titia De Lange · Rockefeller University · T32 · FY2008 · CA
Immune activation by cetuximab in head and neck cancer patients
$367,388Robert L Ferris · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · DE
Antigen specific T cell accumulation in the CNS
$367,370Zsuzsanna Fabry · University Of Wisconsin-Madison · R56 · FY2008 · NS
The Role of IgE in Airway Inflammation
$367,369Yang-Xin Fu · University Of Chicago · R01 · FY2006 · HL
Immunotherapeutic Modalities for K-ras Mutant Lung Cancer: Sex- and Cell Type-Specific Roles of IL-6/STAT3 signaling
$367,325Seyed Javad Mirhassani Moghaddam · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Assessing the determinants of durable protective immunity in SARS-CoV-2 infected human subjects
$367,304Stefan H.i. Kappe · Seattle Children'S Hospital · U01 · FY2022 · AI
Clinical trial development in cancer vaccines
$367,265Samir Khleif · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Tumor-intrinsic signaling pathways restrict anti-tumor immunity in hepatocellular carcinoma
$367,259Amaia Lujambio · Icahn School Of Medicine At Mount Sinai · R37 · FY2024 · CA
Integrative approach to identify genomic features that shape the immune landscape and predict immunotherapy response in diffuse large B cell lymphoma
$367,186Justin P. Kline · University Of Chicago · R01 · FY2023 · CA
Integrative approach to identify genomic features that shape the immune landscape and predict immunotherapy response in diffuse large B cell lymphoma
$367,186Justin P. Kline · University Of Chicago · R01 · FY2025 · CA
CD4-Independent Vaccinations for Pulmonary Infections
$367,184Jay K Kolls · Lsu Health Sciences Center · P01 · FY2008 · HL
Role of B-cell mediated anti-tumor antibodies in responses to radiation and immunotherapy in HNSCC
$367,178Andrew B. Sharabi · University Of California, San Diego · R01 · FY2021 · DE
Targeting Metastatic Breast Cancer with Human Antibodies
$367,153Scripps Research Institute · R01 · FY2005 · CA
Development of Chimeric Antigen Receptors Targeting Multiple Myeloma
$367,151James Kochenderfer · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Clinical Scholars Biomedical Research Training Program
$367,150Ping Chi · Sloan-Kettering Inst Can Research · T32 · FY2019 · CA
CAR NKT Cell Immunotherapy of Neuroblastoma
$367,144Leonid S Metelitsa · Baylor College Of Medicine · R01 · FY2024 · CA
CAR NKT Cell Immunotherapy of Neuroblastoma
$367,144Leonid S Metelitsa · Baylor College Of Medicine · R01 · FY2025 · CA
CAR NKT Cell Immunotherapy of Neuroblastoma
$367,144Leonid S Metelitsa · Baylor College Of Medicine · R01 · FY2023 · CA
CAR NKT Cell Immunotherapy of Neuroblastoma
$367,144Leonid S Metelitsa · Baylor College Of Medicine · R01 · FY2021 · CA
Role of YAP in Treg Function and YAP Targeting for Cancer Immunotherapy
$367,087Drew M. Pardoll · Johns Hopkins University · R01 · FY2022 · CA
A PLATFORM TECHNOLOGY TO GENETICALLY REPROGRAM CANCER CELLS FOR ENHANCED IMMUNOTHERAPY
$367,087Stephany Yi Tzeng · Johns Hopkins University · R37 · FY2023 · CA
Role of intratumoral high endothelial venules in tumor immunity
$367,087Masanobu Komatsu · Johns Hopkins University · R01 · FY2023 · CA
Targeting Tumor Metabolism as a Means of Enhancing Immunotherapy
$367,087Robert David Leone · Johns Hopkins University · R01 · FY2022 · CA